ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 957,57
0,54%
Dow Jones
38 675,68
1,18%
DAX
18 001,60
0,54%
Brent Oil
82,765
0,00%
Bitcoin
63 692,59
-0,31%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Harpoon Therapeutics Inc (HARP)

  7. Harpoon Therapeutics Inc (HARP) Actualités

HARP Harpoon Therapeutics Inc

23,01
0,00 (0,00%)
03 Mai 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Harpoon Therapeutics Inc HARP NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,00 0,00% 23,01 02:00:00
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
23,01 23,01
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
11/3/202422:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/3/202414:55EDGAR2Form POS AM - Post-Effective amendments for registration..
11/3/202414:46EDGAR2Form S-8 POS - Securities to be offered to employees in..
11/3/202413:47EDGAR2Form 8-K - Current report
08/3/202422:04EDGAR2Form 8-K - Current report
28/2/202413:37EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
28/2/202413:34EDGAR2Form 8-K - Current report
22/2/202414:32EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
22/2/202414:31EDGAR2Form 8-K - Current report
08/2/202413:00EDGAR2Form DEFM14A - Definitive proxy statement relating to merger..
06/2/202422:15EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
29/1/202422:52EDGAR2Form PREM14A - Preliminary proxy statements relating to..
29/1/202422:28EDGAR2Form 8-K - Current report
10/1/202421:07PRNUSKuehn Law Encourages AMAM, HARP, AXNX, and CPE Investors to..
09/1/202412:12IHMARKETNEWSWall Street Highlights: HPE and Juniper Networks in..
08/1/202423:20EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
08/1/202423:16EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
08/1/202414:04EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
08/1/202414:01EDGAR2Form 8-K - Current report
08/1/202413:30BWMerck to Acquire Harpoon Therapeutics, Further Diversifying..
05/1/202423:04EDGAR2Form S-8 - Securities to be offered to employees in employee..
26/12/202313:30GLOBEHarpoon Therapeutics Strengthens Leadership Team
22/12/202322:06EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
20/12/202306:15EDGAR2Form EFFECT - Notice of Effectiveness
19/12/202313:30GLOBEHarpoon Therapeutics Abstract for HPN328 Accepted for Rapid..
12/12/202302:15GLOBEHarpoon Therapeutics Presents HPN217 Phase 1 Clinical Data..
08/12/202322:08EDGAR2Form S-3 - Registration statement under Securities Act of..
28/11/202322:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/11/202322:14EDGAR2Form 8-K - Current report
24/11/202320:06EDGAR2Form 8-K - Current report
24/11/202320:01EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
09/11/202322:28EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202322:11EDGAR2Form 8-K - Current report
09/11/202322:01GLOBEHarpoon Therapeutics Reports Third Quarter 2023 Financial..
03/11/202321:05EDGAR2Form SC 13G - Statement of acquisition of beneficial..
02/11/202314:15GLOBEHarpoon Therapeutics Abstract for HPN217 Accepted for..
26/10/202323:00EDGAR2Form SC 13G - Statement of acquisition of beneficial..
23/10/202314:00EDGAR2Form 8-K - Current report
23/10/202313:17GLOBEHarpoon Therapeutics Announces Up to $150 Million Private..
21/10/202317:31GLOBEHarpoon Therapeutics Announces Updated Interim Tolerability..
16/10/202322:05GLOBEHarpoon Therapeutics to Host Webcast Reviewing HPN328..
09/10/202322:17GLOBEHarpoon Therapeutics to Present Interim Tolerability and..
02/10/202323:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/9/202309:00GLOBEHarpoon Therapeutics Presents HPN217 Interim Phase 1 Data at..
15/9/202313:15GLOBEHarpoon Therapeutics Announces First Patients with Small..
13/9/202323:12DJNHarpoon Shares Drop 7.3% as AbbVie Declines License Option
13/9/202322:55DJNHarpoon Therapeutics Says AbbVie Declines to Exercise..
13/9/202322:15EDGAR2Form 8-K - Current report
13/9/202322:05GLOBEHarpoon Therapeutics Provides an Update on the HPN217..
06/9/202313:30GLOBEHarpoon Therapeutics Abstract for HPN217 Accepted for Poster..

Dernières Valeurs Consultées

NASDAQ
HARP
Harpoon Therapeutics
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés